Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
UBS Group
UBS
$173B
| $2.01M | ﹤0.01% |
113,660
+39,001
| +52% | +$741K |
|
2302
Innospec
IOSP
$2.12B
| $2.01M | ﹤0.01% |
29,238
-127,400
| -81% | -$8.86M |
|
2303
Republic Bancorp
RBCAA
$1.97B
| $2M | ﹤0.01% |
52,301
+2,834
| +6% | +$110K |
|
|
XELA
2304
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $2M | ﹤0.01% |
30
+24
| +400% | +$1.6M |
|
|
MODV
2305
DELISTED
ModivCare
MODV
| $2M | ﹤0.01% |
28,925
-22,600
| -44% | -$1.47M |
|
2306
MVB Financial
MVBF
$400M
| $1.99M | ﹤0.01% |
+100,851
| New | +$1.98M |
|
|
LTC
2307
LTC Properties
LTC
$2.06B
| $1.99M | ﹤0.01% |
52,404
-181,189
| -78% | -$7.13M |
|
|
CCI.PRA
2308
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $1.99M | ﹤0.01% |
1,779
| – | – |
|
2309
Coca-Cola Consolidated
COKE
$12.5B
| $1.99M | ﹤0.01% |
115,090
+102,620
| +823% | +$1.96M |
|
|
BUFF
2310
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $1.99M | ﹤0.01% |
49,879
+35,527
| +248% | +$1.28M |
|
|
IVTY
2311
DELISTED
Invuity, Inc
IVTY
| $1.98M | ﹤0.01% |
513,666
+95,550
| +23% | +$436K |
|
2312
Virtu Financial
VIRT
$5.08B
| $1.98M | ﹤0.01% |
59,859
-356,352
| -86% | -$9.22M |
|
2313
ePlus
PLUS
$2.41B
| $1.97M | ﹤0.01% |
50,756
+20,144
| +66% | +$776K |
|
|
EDN
2314
Edenor
EDN
$1.18B
| $1.97M | ﹤0.01% |
34,262
+10,999
| +47% | +$624K |
|
2315
CALL
Pilgrim's Pride
PPC
$6.5B
| $1.97M | ﹤0.01% |
+80,000
| New | +$2.15M |
|
|
VSLR
2316
DELISTED
VIVINT SOLAR, INC.
VSLR
| $1.97M | ﹤0.01% |
+539,395
| New | +$1.86M |
|
2317
Winnebago Industries
WGO
$855M
| $1.97M | ﹤0.01% |
52,274
-300,627
| -85% | -$13.9M |
|
2318
Exponent
EXPO
$3.21B
| $1.96M | ﹤0.01% |
49,804
-178,192
| -78% | -$6.74M |
|
|
ADMS
2319
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.96M | ﹤0.01% |
81,820
-575,263
| -88% | -$18.1M |
|
|
XLRN
2320
PUT
DELISTED
Acceleron Pharma
XLRN
| $1.96M | ﹤0.01% |
+50,000
| New | +$2.13M |
|
|
GRMN
2321
Garmin
GRMN
$57.1B
| $1.95M | ﹤0.01% |
33,104
-186,690
| -85% | -$11.4M |
|
2322
BRC Group Holdings
RILY
$287M
| $1.95M | ﹤0.01% |
100,000
| – | – |
|
2323
Aclaris Therapeutics
ACRS
$732M
| $1.94M | ﹤0.01% |
110,827
+99,029
| +839% | +$2.1M |
|
2324
Middlesex Water
MSEX
$1.07B
| $1.94M | ﹤0.01% |
52,807
-11,782
| -18% | -$436K |
|
2325
Neurogene
NGNE
$654M
| $1.94M | ﹤0.01% |
6,871
-36
| -0.5% | -$9.94K |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.